Secondary prevention may be effective in reducing the incidence of<unk>  cancer, if treated early at the dysplasia stage with monoclonal antibody therapy. At present, there is no particular program in place to reduce the incidence of<unk>  cancer.
Esophageal cancer secondary prevention
Esophageal cancer primary prevention
Laryngeal cancer secondary prevention
Nasopharyngeal carcinoma secondary prevention
Stomach cancer secondary prevention
Esophageal stricture secondary prevention
Esophageal stricture primary prevention
Barrett's esophagus primary prevention